Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

392
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
392
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

764
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
764
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

242
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
242

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-Specific Blood Pressure and Brain Microvascular Traits in a Model of Low-Renin Hypertension.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

Coming Back to Life: Resilience of Endothelium Despite the Burden of Hypertension.

Circulation research·2025
Same author

Anchoring Protein Increases Cerebrovascular Responses and Blood Pressure During Hypertension: Turn Round Quick and Start to Run.

Arteriosclerosis, thrombosis, and vascular biology·2024
Same author

Circadian Mechanisms in Cardiovascular and Cerebrovascular Disease.

Circulation research·2024
Same author

Hypertension: Causes and Consequences of Circadian Rhythms in Blood Pressure.

Circulation research·2024
Same author

Brain endothelium: a nexus for cerebral small vessel disease.

European heart journal·2023

Related Experiment Video

Updated: Oct 20, 2025

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.8K

Microvascular changes that stagger the mind.

Frank M Faraci

    The Journal of Clinical Investigation
    |September 15, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Hypertension impairs brain blood flow and cognitive function by affecting capillary endothelial cells and K+ channels. Treatments targeting these mechanisms, like eplerenone, may restore neurovascular coupling.

    More Related Videos

    Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
    07:30

    Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

    Published on: April 23, 2021

    3.2K
    A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
    05:12

    A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

    Published on: November 22, 2024

    835

    Related Experiment Videos

    Last Updated: Oct 20, 2025

    Using Retinal Imaging to Study Dementia
    09:17

    Using Retinal Imaging to Study Dementia

    Published on: November 6, 2017

    21.8K
    Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
    07:30

    Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

    Published on: April 23, 2021

    3.2K
    A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
    05:12

    A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

    Published on: November 22, 2024

    835

    Area of Science:

    • Cardiovascular Science
    • Neuroscience
    • Vascular Biology

    Background:

    • Hypertension is a primary driver of cognitive decline and dementia.
    • The precise vascular mechanisms underlying hypertension-induced brain damage remain unclear.
    • Neurovascular coupling (NVC) deficits are implicated in the vascular component of cognitive impairment.

    Purpose of the Study:

    • To investigate the impact of hypertension on capillary endothelium and ion channels.
    • To elucidate the role of inward-rectifier K+ channels (Kir2.1) in hypertension-related NVC dysfunction.
    • To identify potential therapeutic targets for reversing hypertension-induced cognitive deficits.

    Main Methods:

    • Utilized a hypertension model to assess end-organ effects.
    • Examined the function of capillary endothelium and Kir2.1 channels.
    • Evaluated the effects of amlodipine, losartan, and eplerenone on NVC.

    Main Results:

    • Hypertension impairs NVC by affecting capillary endothelium and Kir2.1 channels, disrupting signal propagation and vasodilation.
    • Amlodipine partially restored NVC, while losartan did not.
    • Eplerenone, in combination with losartan, improved NVC, indicating a role for aldosterone.

    Conclusions:

    • Endothelial cells and Kir2.1 channels are critical in hypertension-induced NVC impairment.
    • Targeting these mechanisms offers a potential strategy to prevent or reverse cognitive deficits associated with hypertension.
    • Aldosterone may play a significant role in regulating NVC during hypertension.